Fundz

Chrysalis Biotherapeutics reported raising $515,000 in an initial SEC Form D filing, from an offering of $3 Million

PRIVATEMar 22, 2024Late filing, first sale Nov 28, 2023$515K of $3M raised

Amount Raised

$515,000

$515,000 sold, per SEC Form D (first sale Nov 28, 2023)

Round Type

Seed

GalvestonBiotechnologyHealthcare

Quick answer

Chrysalis Bio Therapeutics raised $515,000 in a Seed round, dated November 28, 2023. Chrysalis Bio Therapeutics is based in Galveston, Texas, United States.

How much did Chrysalis Bio Therapeutics raise?
Chrysalis Bio Therapeutics raised $515,000 in a Seed round on November 28, 2023.
What does Chrysalis Bio Therapeutics do?
Chrysalis BioTherapeutics, Inc. is a biopharmaceutical development company located in Galveston, TX.
Where is Chrysalis Bio Therapeutics based and how big is it?
Chrysalis Bio Therapeutics is based in Galveston, Texas, United States.
Who are the decision-makers at Chrysalis Bio Therapeutics?
Fundz holds 2 contacts at Chrysalis Bio Therapeutics, including the CEO. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Biotechnology around the same time

Companies in the same sectors as Chrysalis Bio Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Avant Sciences raised $175K on January 12, 2024.
  • Streamex Corp. raised $1.5M (Seed) on January 12, 2024.
  • Lykos Therapeutics raised an undisclosed amount (Series A) on January 5, 2024.
  • ViaLase raised $45M (Seed) on January 5, 2024.
  • Reimagine Care raised an undisclosed amount (Corporate Round) on January 4, 2024.
  • Greenbrook TMS raised $5.3M (Debt Financing) on December 28, 2023.

Who to call at Chrysalis Bio Therapeutics, and when

A new round usually means Chrysalis Bio Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Chrysalis Bio Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Chrysalis Bio Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Chrysalis Bio Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Chrysalis Bio Therapeutics

Location

2200 MARKET ST, SUITE 606

Galveston, Texas, United States

About

Chrysalis BioTherapeutics, Inc. is a biopharmaceutical development company located in Galveston, TX. TP508 (rusalatide acetate) is licensed from The University of Texas Medical Branch (UTMB) at Galveston, TX. Although TP508 has shown potential efficacy in stimulating early tissue repair in human clinical trials, it is not yet FDA-approved and is currently only available for investigational use.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Chrysalis Bio Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsDarrell C., CEO hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Chrysalis Bio Therapeutics's next move

See what Strategic adds

Chrysalis Bio Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.